Trial Profile
Non-Interventional Observational Study on the Influence of Pramipexole (PPX) on Sensory Symptoms of Restless Legs Syndrome (RLS).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2014
Price :
$35
*
At a glance
- Drugs Pramipexole (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 31 Dec 2009 Actual patient number changed from 1498 to 1504 as reported by ClinicalTrials.gov.
- 31 Dec 2009 Actual end date changed from Sep 2009 to October 2009 as reported by ClinicalTrials.gov.
- 02 Dec 2009 Actual patient number changed from 1380 to 1498 as reported by ClinicalTrials.gov.